Skip to main content
. 2022 May 5;5(3):e620. doi: 10.1002/hsr2.620

Table 3.

Description of the Braden scores among surveyed patients.

Level of PrUs risk Overall Braden scores (n = 318) Braden scores among patients had MDRPrUs (n = 121) Braden scores among patients free of MDRPrUs (n = 197)
≤9 (pevere risk) 81 (25.5%) 56 (46.3%) 25 (12.7%)
10–12 (high risk) 51 (16.0%) 24 (19.8%) 27 (13.7%)
13–14 (moderate risk) 49 (15.4%) 13 (10.7%) 36 (18.3%)
15–18 (mild risk) 137 (43.1%) 28 (23.1%) 109 (55.3%)